Showing results (311-320 of 369) with videos related to

Sort By:
Pageof 37
British Journal of Haematology|October 29, 1998
Detection of karyotypic aberrations in acute myeloblastic leukaemia: a prospective comparison between PCR/FISH and standard cytogenetics in 140 patients with de novo AMLJ Krauter, W Peter, U Pascheberg, et al.
British Journal of Clinical Pharmacology|August 5, 1998
Pharmacokinetics of recombinant human interleukin-2 in advanced renal cell carcinoma patients following subcutaneous applicationG I Kirchner, A Franzke, J Buer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 23, 2004
Phase I and pharmacokinetic study of TZT-1027, a novel synthetic dolastatin 10 derivative, administered as a 1-hour intravenous infusion every 3 weeks in patients with advanced refractory cancerP Schöffski, B Thate, G Beutel, et al.
Blood|September 1, 1995
Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patientsH J Kolb, A Schattenberg, J M Goldman, et al.
Bone Marrow Transplantation|December 14, 2004
Dose-escalated treosulphan in combination with cyclophosphamide as a new preparative regimen for allogeneic haematopoietic stem cell transplantation in patients with an increased risk for regimen-related complicationsD W Beelen, R Trenschel, J Casper, et al.
European Journal of Cancer (Oxford, England : 1990)|April 9, 2002
Clinical phase II study and pharmacological evaluation of rubitecan in non-pretreated patients with metastatic colorectal cancer-significant effect of food intake on the bioavailability of the oral camptothecin analogueP Schöffski, A Herr, J B Vermorken, et al.
Blood|January 7, 1998
A randomized, double-blind, placebo-controlled, phase III study of filgrastim in remission induction and consolidation therapy for adults with de novo acute myeloid leukemia. The International Acute Myeloid Leukemia Study GroupG Heil, D Hoelzer, M A Sanz, et al.
Blood|May 26, 1999
HLA-B8 and HLA-A3 coexpressed with HLA-B8 are associated with a reduced risk of the development of chronic myeloid leukemia. The Chronic Leukemia Working Party of the EBMTE F Posthuma, J H Falkenburg, J F Apperley, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 9, 2007
Efficacy, safety and tolerability of recombinant factor VIII (REFACTO) in patients with haemophilia A: interim data from a postmarketing surveillance study in Germany and AustriaH Pollmann, D Externest, A Ganser, et al.
Blood|December 15, 1995
Monosomy 7 and activating RAS mutations accompany malignant transformation in patients with congenital neutropeniaR Kalra, D Dale, M Freedman, et al.
Pageof 37